Valbenazine + Mao Inhibitors Interaction
Majorinteraction on record
Description
Increased exposure to valbenazine and active metabolite, raising risk of exposure-related adverse reactions. Dose reduction to 40 mg once daily recommended.
Mechanism
Inhibition of CYP3A4-mediated metabolism increasing valbenazine and active metabolite exposure
Source: NLP:valbenazine